Fosaprepitant Dimeglumine Injection shortage
To Be Discontinued 1 presentations · 1 manufacturers · first FDA posting Apr 8, 2026 · last update Apr 8, 2026
Manufacturers: Fresenius Kabi USA, LLC
Stated reasons (per FDA): Not stated
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Fosaprepitant Dimeglumine, Injection, 150 mg/5 mL (NDC 63323-972-10) | Fresenius Kabi USA, LLC | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted Apr 8, 2026 Updated Apr 8, 2026 Discontinued Apr 8, 2026 |